These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1055303)

  • 1. Treatment of acute myelogenous leukaemia in adults. A retrospective study of 70 patients (1968-1973).
    Willemze R; Hartgrink-Groeneveld CA; Speck B; Eernisse JG
    Neth J Med; 1975; 18(1):17-28. PubMed ID: 1055303
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognosis of acute leukaemia in adults.
    Penington DG; Keating MJ
    Med J Aust; 1974 Jun; 1(26):1031-5. PubMed ID: 4527947
    [No Abstract]   [Full Text] [Related]  

  • 3. Absence of the influence of age on remission rate and duration of remission in a group of thirty-four patients with acute myeloid leukaemia.
    De Vries EG; Mulder NH; Houwen B; Haaxma-Reiche H; De Vries-Hospers HG
    Neth J Med; 1980; 23(6):241-5. PubMed ID: 6936611
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Biomedicine; 1973 May; 18(3):192-8. PubMed ID: 4517790
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of acute myelogenous leukemia in adults; an account of the years 1968 to 1975].
    Willemze R; den Ottolander GJ; Heering KJ; Brand A; Zwaan FE; Haak HL; Hartgrink-Groeneveld CA; Jansen J; Eernisse JG
    Ned Tijdschr Geneeskd; 1977 Nov; 121(46):1843-7. PubMed ID: 270615
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of non-lymphoid acute leukemias].
    Mandelli F
    Minerva Med; 1975 Jul; 66(51):1546-52. PubMed ID: 1057048
    [No Abstract]   [Full Text] [Related]  

  • 7. The management of blastic crisis of chronic myeloid leukaemia with thioguanine, rubidomycin, ARA C and prednisone (TRAP regimen).
    Resegotti L; Falda M; Rossi M; Infelise VE
    Panminerva Med; 1973 Sep; 15(9):275-7. PubMed ID: 4533778
    [No Abstract]   [Full Text] [Related]  

  • 8. [Difficulties of remission induction treatment of acute myeloblastic leukemia].
    Fière D; Bryon PA; Martin C; Revol L
    Sem Hop; 1974 May; 50(25):1691-4. PubMed ID: 4369538
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of acute nonlymphoid leukaemia with five different schedules including cytosine arabinoside and 6-thioguanine.
    Mandelli F; Amadori S; De Luca AM; Deriu L; De Rossi G; Isacchi G; Mariani G; Monarca B; Papa G; Di Giovanni F
    Haematologica; 1977 Apr; 62(2):167-84. PubMed ID: 406174
    [No Abstract]   [Full Text] [Related]  

  • 10. [Quality of survival in patients with acute leukemia subjected to combination drug therapy].
    Almici C; Inzoli MR
    G Clin Med; 1976; 57(5-6):183-91. PubMed ID: 1070454
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of acute myeloblastic leukemia with cytosine arabinoside combined with daunorubicin or ifosfamide or thioguanine].
    Büchner T; Kamanabroo D; Hiddemann W; Urbanitz D
    Verh Dtsch Ges Inn Med; 1978; (84):145-8. PubMed ID: 283634
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative observations in the treatment of acute leukaemia.
    Gráf F; Fekete S; Benedek S; Sréter L; Takácsi-Nagy L
    Haematologia (Budap); 1976; 10(1):81-7. PubMed ID: 1070470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
    Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
    Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experiences in the induction of remission and in maintenance therapy in acute myeloblastic leukemia in adults with the RAMPO scheme].
    Höche D; Herold M; Fink R; Anger G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):237-43. PubMed ID: 6168533
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of acute leukemia in adults. Results with a combination of potent cytotoxic drugs.
    Stavem P; Gjemdal T
    Acta Med Scand; 1974; 196(1-2):121-5. PubMed ID: 4529548
    [No Abstract]   [Full Text] [Related]  

  • 17. [Letter: New combination drug therapy of acute myeloid leukemia].
    Fière D; Bryon PA; Martin C; Péaud PY
    Nouv Presse Med; 1975 Sep; 4(29):2114 (1). PubMed ID: 1058467
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic results in acute myelogenous leukemia in the years from 1970 to 1982].
    Kurrle E; Hoelzer D; Heimpel H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):698-709. PubMed ID: 2416646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [General remarks on the treatment of acute leukemias].
    Bernard J
    Minerva Med; 1975 Jul; 66(52):2625-8. PubMed ID: 1057057
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute myeloid leukemia in the adult.
    di Cato MA
    Bull Soc Sci Med Grand Duche Luxemb; 1975 Nov; 112(2):129-33. PubMed ID: 1060522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.